PTGX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:53):
Our systems believe the stock currently is undervalued by 0.20% compare to its pairs and should correct upwards.

Stats
आज की मात्रा	54 750
औसत मात्रा	600 029
बाजार मूल्य	1.83B
EPS	$3.41 ( Q1 \| 2024-05-07 )
अगली कमाई की तारीख	( $-0.500 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	12.29 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0880 (0.28%)

AADI -2.92%

ABCL 2.01%

ABCM 0.04%

ABEO -2.84%

ABIO -0.98%

ABOS 0.93%

ABSI 3.06%

ABUS -2.62%

ABVX -3.53%

ACAD -0.96%

ACER -17.95%

ACET -3.40%

ACGN 1.29%

ACHL -4.15%

ACHV -1.73%

ACIU -0.50%

ACLX -0.20%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.77%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT -0.30%

ADTX -3.47%

ADVM -3.04%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -2.10%

AGEN -0.81%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.28%

AKRO -2.56%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.70%

ALEC -4.13%

ALGS -2.41%

ALKS -0.23%

ALLK -8.90%

ALLO -6.67%

ALLR -4.23%

ALNA 3.16%

ALNY 1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.05%

ALVR 0.93%

ALXN 0.00%

ALXO -10.94%

ALZN 5.07%

AMRN 0.26%

AMTI -3.13%

ANAB 0.42%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.44%

ANPC -3.15%

APGE -1.07%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.25%

APLT -4.16%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.26%

ARDS -14.23%

ARDX -0.91%

ARGX -0.96%

ARNA 0.00%

ARPO -0.90%

ARQT -0.31%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.95%

ARWR -2.16%

ASLN -3.21%

ASMB -3.70%

ASND -1.27%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.98%

ATOS 4.85%

ATRA -2.49%

ATXI 1.93%

ATXS -1.05%

AUPH -1.17%

AURA -0.15%

AUTL -1.87%

AVBP -2.79%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.43%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.89%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.94%

BCAB 2.61%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.48%

BCTX 8.67%

BCTXW -19.63%

BCYC 0.64%

BDRX -6.00%

BDTX -0.85%

BEAM -0.04%

BFRA -2.91%

BGNE -2.19%

BIOR -1.72%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.41%

BMEA -9.65%

BMRN 0.38%

BNOX -2.22%

BNTC -2.11%

BNTX -1.11%

BOLD -8.80%

BOLT -0.22%

BPMC -1.34%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.38%

BTAI 26.27%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.76%

CADL -0.53%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.85%

CARM 11.79%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.99%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -3.09%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.43%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.78%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.62%

CGEN -3.31%

CGON -0.13%

CGTX -4.55%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING 0.67%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.43%

CLNNW 0.00%

CLRB 6.63%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -1.96%

CMND 3.63%

CMPI 0.00%

CMPX -10.74%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.85%

CNST 0.00%

CNTA -0.79%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.49%

CORT 2.01%

COYA -1.46%

CPRX -0.40%

CRBP -2.10%

CRBU -4.56%

CRDF -2.21%

CRGX 1.34%

CRIS -0.38%

CRNX -5.79%

CRSP 1.00%

CRTX 2.63%

CRVO -2.54%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -3.66%

CTXR 1.30%

CUE 3.61%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 8.81%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.52%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 30.43%

DNLI -1.61%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.81%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.41%

EDSA -1.00%

EFTR 7.54%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.39%

ELOX 7.69%

ELTX -0.88%

ELVN -4.59%

ELYM 0.56%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.93%

ENTA -0.24%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.45%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX -0.23%

EXAI -0.44%

EXEL -0.16%

EYEG -0.69%

EYEN 1.52%

EYPT 0.24%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -18.11%

FBRX -0.04%

FDMT -4.59%

FENC -1.29%

FGEN -5.09%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.38%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.71%

FULC -3.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.83%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.43%

GHRS -2.85%

GLMD 0.31%

GLPG -2.30%

GLSI 2.80%

GLTO -1.20%

GLUE -1.58%

GLYC -9.09%

GMAB -0.53%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.98%

GNTA 3.94%

GOSS -7.84%

GOVX 2.95%

GOVXW -49.04%

GPCR -7.14%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.14%

GRTX 0.00%

GTHX 0.23%

GUTS -5.31%

GXGXW 41.67%

GYRE -6.02%

HALO -0.71%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.56%

HRMY 1.10%

HRTX 1.64%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.99%

ICCC 0.22%

ICPT 0.21%

ICU 16.67%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.46%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.58%

IMMX -7.76%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.75%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.55%

INAB 0.59%

INBX 0.07%

INCY -0.74%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.80%

INO -1.95%

INSM -0.66%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS -0.17%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -3.15%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -4.13%

JAGX 0.28%

JANX -4.08%

JAZZ -0.65%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.95%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -9.25%

KRTX 0.03%

KRYS -0.86%

KTRA 16.07%

KTTA 8.16%

KTTAW 0.92%

KURA -1.66%

KYMR -2.05%

KYTX -3.75%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.08%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.07%

LENZ -4.03%

LEXX 0.00%

LEXXW -14.63%

LGND -1.27%

LGNDV 0.00%

LGVN -8.78%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.43%

LPCN -5.03%

LPTX -1.65%

LQDA -0.24%

LRMR -1.78%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.86%

LXRX -2.05%

LYEL -35.45%

LYRA 2.83%

MACK 0.10%

MBIO -8.94%

MBRX -2.86%

MCRB 1.27%

MDGL -2.55%

MDNA -13.16%

MDWD 0.10%

MDXG -2.36%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.61%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.11%

MLYS -5.67%

MNKD -1.14%

MNMD 0.00%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.34%

MREO -4.15%

MRKR 2.68%

MRNA -4.67%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.19%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 8.38%

NAMS 1.73%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.93%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.65%

NKTX -4.57%

NLSP -2.88%

NLSPW 26.67%

NMRA -0.91%

NMTR -42.97%

NOVN -24.84%

NRBO 11.36%

NRIX -1.11%

NRSN -3.63%

NRSNW 0.00%

NRXP -6.69%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.25%

NTRBW -31.07%

NUVL -1.97%

NVAX -1.14%

NVCT 3.94%

NVIV -34.28%

NXTC -3.24%

NYMX -0.05%

OABI 0.33%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 4.27%

OCS -1.02%

OCUL -1.98%

OCUP 1.64%

ODT -4.27%

OKYO 1.51%

OLMA -5.61%

OMER -0.77%

OMGA 6.28%

ONCO 7.71%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -0.33%

ORGS -4.26%

ORIC -3.41%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.31%

PBLA -7.50%

PBM -7.29%

PBYI 1.01%

PCSA 0.00%

PCVX -0.23%

PDSB -0.95%

PEPG 1.55%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.26%

PHIO -4.96%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.64%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.60%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.89%

PRQR -0.01%

PRTA -2.41%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.31%

PTE -0.82%

PTGX -1.55%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 4.43%

QLGN -3.72%

QNCX 5.67%

QNRX 0.37%

QSI -11.66%

QSIAW -3.13%

QTTB -4.51%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -3.22%

RARE 0.98%

RCKT -8.09%

REGN -0.72%

RENB -3.11%

REPL -3.00%

RETA 0.02%

REUN -0.89%

REVB -0.47%

REVBU 3.46%

REVBW 4.38%

RGLS -4.72%

RGNX -5.28%

RIGL -3.28%

RLAY -4.60%

RLMD 0.33%

RLYB 1.01%

RNA -0.41%

RNAC -5.65%

RNAZ -0.11%

RNXT 1.88%

ROIV -1.99%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.27%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -30.00%

RVNC 1.91%

RVPH -1.02%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.47%

RYTM -5.92%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -3.78%

SAVA -0.41%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -1.01%

SCPS 0.00%

SEEL -4.09%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.86%

SGMT -0.96%

SGTX -2.56%

SIOX 22.63%

SLDB -4.40%

SLGL 4.00%

SLN -4.21%

SLNO -2.58%

SLRX 5.91%

SLS -3.00%

SMMT -2.50%

SNDX 0.61%

SNGX -3.02%

SNPX -3.23%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -1.66%

SPRO 0.04%

SRNE -31.19%

SRPT -1.01%

SRRA 0.00%

SRRK -2.29%

SRZN -2.45%

STAB 0.00%

STOK -5.21%

STRO -3.01%

STSA 0.00%

STTK -4.64%

SURF -0.93%

SVRA -3.03%

SWTX 0.11%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.19%

TARS -0.08%

TBPH 0.36%

TCBP 0.00%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.68%

TECH -0.08%

TENX -1.27%

TERN -6.34%

TFFP -3.05%

TGTX -3.00%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.59%

TNXP -5.34%

TNYA -8.58%

TPST 2.52%

TRDA -3.86%

TRVI 0.77%

TRVN 5.02%

TSHA -24.29%

TSVT -2.40%

TTNP -9.27%

TVTX 0.25%

TYRA -7.66%

UBX -0.96%

UNCY -3.39%

URGN -1.96%

UTHR -0.45%

VACC 11.36%

VALN -2.89%

VAXX 77.82%

VBIV -0.45%

VBLT -8.77%

VCEL 0.29%

VCNX 10.35%

VCYT -1.14%

VERA -2.90%

VERU 0.84%

VERV -2.58%

VIGL 6.18%

VINC 1.62%

VIR 0.76%

VIRI -1.77%

VIRX 3.33%

VKTX -1.05%

VLON -13.04%

VNDA -2.52%

VOR -2.42%

VRCA 0.50%

VRDN -4.39%

VRNA -1.40%

VRPX 0.38%

VRTX 0.08%

VSTM -3.38%

VTGN -1.81%

VTVT -2.97%

VTYX -0.42%

VXRT -2.67%

VYGR -1.92%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.61%

XBIO 0.93%

XBIT 0.83%

XCUR 3.61%

XENE -3.05%

XERS 1.90%

XFOR 3.73%

XLO 4.43%

XLRN 0.00%

XNCR 0.16%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -9.74%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.19%

ZNTL -2.62%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-13	Patel Dinesh V Ph D	Sell	1 000	Common Stock
2024-06-07	Waddill William D.	Buy	8 000	Common Stock
2024-06-07	Waddill William D.	Sell	8 000	Stock Option (right to buy)
2024-06-07	Waddill William D.	Sell	8 000	Common Stock
2024-06-07	Patel Dinesh V Ph D	Sell	35 000	Common Stock

INSIDER POWER
59.83
Last 97 transactions
Buy: 2 539 640 \| Sell: 469 541

सहसंबंध (AI algo v.1.1b): Undervalued: 0.20% $31.27 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.50 (neutral)

छोटा: 1.00 (very strong)

Signal:(63.082) Expect same movement, but be aware

Protagonist Therapeutics सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
ICFI	0.86
SRTS	0.854
KYMR	0.846
PPH	0.846
CREX	0.833
REYN	0.829
REGN	0.828
EOLS	0.822
MRUS	0.817
LRMR	0.813

10 सबसे अधिक नकारात्मक सहसंबंध
VALN	-0.806

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Protagonist Therapeutics सहसंबंध - मुद्रा/वस्त्र

-0.46
( neutral )

-0.52
( weak negative )

0.00
( neutral )

-0.46
( neutral )

-0.61
( weak negative )

0.40
( neutral )

Protagonist Therapeutics वित्तीय

Annual	2023
राजस्व:	$60.00M
सकल लाभ:	$56.69M (94.48 %)
EPS:	$-1.390

FY	2023
राजस्व:	$60.00M
सकल लाभ:	$56.69M (94.48 %)
EPS:	$-1.390

FY	2022
राजस्व:	$26.58M
सकल लाभ:	$25.55M (96.12 %)
EPS:	$-2.52

FY	2021
राजस्व:	$27.36M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-2.71

Financial Reports:

No articles found.

Protagonist Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Protagonist Therapeutics

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.